Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.

Original publication

DOI

10.1016/j.tibtech.2014.05.007

Type

Journal article

Journal

Trends Biotechnol

Publication Date

09/2014

Volume

32

Pages

436 - 440

Keywords

cell therapies, regenerative medicine, stem cells, strategic partnerships, translation, Cooperative Behavior, Drug Industry, Public-Private Sector Partnerships, Regenerative Medicine, Research, Universities